We serve Chemical Name:5-fluoro-1H-indol-6-amine CAS:121716-63-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-fluoro-1H-indol-6-amine
CAS.NO:121716-63-0
Synonyms:1H-Indol-6-amine,5-fluoro
Molecular Formula:C8H7FN2
Molecular Weight:150.15300
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:41.81000
Exact Mass:150.05900
LogP:2.47040
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1H-Indol-6-amine,5-fluoro chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1H-Indol-6-amine,5-fluoro physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1H-Indol-6-amine,5-fluoro Use and application,1H-Indol-6-amine,5-fluoro technical grade,usp/ep/jp grade.
Related News: In the TOP50 list of API export companies in 2017, the geographical clustering of advantageous companies is still obvious. For example, Huahai and Pluo in Zhejiang, CSPC of Hebei, Xinhua Pharmaceutical and Xinfa Pharmaceutical of Shandong rank well. Rank. 5-fluoro-1H-indol-6-amine manufacturer In the TOP50 list of API export companies in 2017, the geographical clustering of advantageous companies is still obvious. For example, Huahai and Pluo in Zhejiang, CSPC of Hebei, Xinhua Pharmaceutical and Xinfa Pharmaceutical of Shandong rank well. Rank. 5-fluoro-1H-indol-6-amine supplier According to statistics, in 2017, China’s total production of chemical drugs reached 3.478 million tons, a year-on-year increase of 1.6%. The main business income showed a steady increase, from 328.972 billion yuan in 2012 to 573.475 billion yuan in 2017. The total profit was 48.644 billion yuan, but profit margins remain low (8.48% in 2017). 5-fluoro-1H-indol-6-amine vendor In the TOP50 list of API export companies in 2017, the geographical clustering of advantageous companies is still obvious. For example, Huahai and Pluo in Zhejiang, CSPC of Hebei, Xinhua Pharmaceutical and Xinfa Pharmaceutical of Shandong rank well. Rank. 5-fluoro-1H-indol-6-amine factory The entire set of results “strongly support” the Darzalex-Rd combo as a new standard of care for newly diagnosed, transplant-ineligible multiple myeloma patients, Thierry Facon, M.D., an investigator of the MAIA trial, said in a statement.
